The risk is highest among patients who switch from anti-androgen to GnRH agonist therapy.
These factors include lower serum albumin levels and vascular access other than an arteriovenous fistula at dialysis initiation.
The time to PSA progression in men with relapsing or locally advanced PCa was similar with intermittent and continuous androgen deprivation.
PSA doubling time increased from 28 to 76 months in patients performing exercise training.
The medications are associated with reduced odds of kidney failure and death compared with angiotensin II receptor blockers.